tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CCCC Stock Latest News

C4 Therapeutics price target raised to $7 from $5 at Barclays
The FlyC4 Therapeutics price target raised to $7 from $5 at Barclays
5d ago
CCCC
C4 Therapeutics: Cemsidomide’s Best-in-Class CELMoD Potential and De‑Risking Clinical Momentum Support Buy Rating
PremiumRatings
C4 Therapeutics: Cemsidomide’s Best-in-Class CELMoD Potential and De‑Risking Clinical Momentum Support Buy Rating
5d ago
CCCC
C4 Therapeutics reports Q4 EPS (18c), consensus (34c)
PremiumThe Fly
C4 Therapeutics reports Q4 EPS (18c), consensus (34c)
6d ago
CCCC
C4 Therapeutics price target raised to $30 from $20 at Brookline
PremiumThe Fly
C4 Therapeutics price target raised to $30 from $20 at Brookline
8d ago
CCCC
C4 Therapeutics announces first patient dosed in Phase 2 MOMENTUM trial
PremiumThe Fly
C4 Therapeutics announces first patient dosed in Phase 2 MOMENTUM trial
9d ago
CCCC
CCCC Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCCCC Upcoming Earnings Report: What to Expect?
15d ago
CCCC
C4 Therapeutics’ Phase 2 Myeloma Trial Moves Forward, Setting Up a Key Catalyst for CCCC Investors
Premium
Company Announcements
C4 Therapeutics’ Phase 2 Myeloma Trial Moves Forward, Setting Up a Key Catalyst for CCCC Investors
2M ago
CCCC
C4 Therapeutics Unveils Multi-Year Cemsidomide Clinical Strategy
Premium
Company Announcements
C4 Therapeutics Unveils Multi-Year Cemsidomide Clinical Strategy
2M ago
8K
CCCC
C4 Therapeutics outlines milestones through 2028
PremiumThe Fly
C4 Therapeutics outlines milestones through 2028
2M ago
CCCC
C4 Therapeutics Sets Up New Combination Trial in Multiple Myeloma: What Investors Should Watch
PremiumCompany Announcements
C4 Therapeutics Sets Up New Combination Trial in Multiple Myeloma: What Investors Should Watch
2M ago
CCCC
C4 Therapeutics price target lowered to $5 from $10 at Barclays
PremiumThe Fly
C4 Therapeutics price target lowered to $5 from $10 at Barclays
3M ago
CCCC
C4 Therapeutics’ Innovative Drug Development and Promising Clinical Trials Support Buy Rating
PremiumRatings
C4 Therapeutics’ Innovative Drug Development and Promising Clinical Trials Support Buy Rating
3M ago
CCCC
C4 Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlyC4 Therapeutics initiated with a Buy at TD Cowen
3M ago
CCCC
C4 Therapeutics files $400M mixed securities shelf
Premium
The Fly
C4 Therapeutics files $400M mixed securities shelf
3M ago
CCCC
C4 Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
C4 Therapeutics Reports Q3 2025 Financial Results
4M ago
CCCC
C4 Therapeutics reports Q3 EPS (44c), consensus (38c)
PremiumThe Fly
C4 Therapeutics reports Q3 EPS (44c), consensus (38c)
4M ago
CCCC
C4 Therapeutics sees cash runway to the end of 2028
PremiumThe Fly
C4 Therapeutics sees cash runway to the end of 2028
4M ago
CCCC
C4 Therapeutics Announces Stock and Warrants Offering
PremiumCompany Announcements
C4 Therapeutics Announces Stock and Warrants Offering
5M ago
8K
CCCC
C4 Therapeutics prices $125M underwritten offering
PremiumThe Fly
C4 Therapeutics prices $125M underwritten offering
5M ago
CCCC
C4 Therapeutics Presents Phase 1 Trial Data
PremiumCompany AnnouncementsC4 Therapeutics Presents Phase 1 Trial Data
5M ago
8K
CCCC
C4 Therapeutics Partners with Pfizer for Clinical Trial
Premium
Company Announcements
C4 Therapeutics Partners with Pfizer for Clinical Trial
5M ago
8K
CCCC
C4 Therapeutics announces trial collab, supply agreement with Pfizer
Premium
The Fly
C4 Therapeutics announces trial collab, supply agreement with Pfizer
5M ago
PFE
CCCC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >